Consistent with this, human CRC HCT-15 and HCT116 cells harboring PIK3CA mutations accelerated cell growth in a glutamine dose-dependent manner (Figure 1a,b), whereas PIK3CA wild type human CRC SW480 cells were not affected by glutamine supplementation (Figure 1c). The gene discussed is PIK3CA; the disease is colorectal carcinoma.